http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-393521-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c91bbf0395db010b4806f50d808c4e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-28 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-24 |
| filingDate | 1971-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1973-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-393521-A1 |
| titleOfInvention | PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 1,3,4,5- TETRAHYDRO - 2H - 1,4-BENZODIAZEPIN-2-ONA. |
| abstract | Process for the preparation of 1,3,4,5-tetrahydra-2H-l, 4-benzodiazepin-2-one derivatives of the general formula i ** (see formula) ** Wherein r means a hydrogen atom or an alkyl group of 1 to 5 carbon atoms and x means a hydrogen or halogen atom or an amino group, characterized in that N-acylated 2-amino-benzophenone derivatives are catalytically hydrogenated. The general formula ii ** (see formula) ** Wherein x'means a hydrogen or halogen atom, or a nitro or amino group, y means a protective group capable of being separated by catalytic hydrogenation and r has the above meanings. (Machine-translation by Google Translate, not legally binding) |
| priorityDate | 1970-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.